Vance Coffman - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Lead Independent Director

Dr. Vance D. Coffman is the Lead Independent Director of Amgen Inc. Dr. Coffman was a director of 3M Company, a consumer and office products and services company, since 2002 and he was a director of Deere Company, a farm and construction machinery company, since 2004. He serves on the Compensation Committee and chairs the Finance Committee of 3M Company and serves on the Corporationrationrate Governance and Executive Committees and chairs the Compensation Committee of Deere Company. Dr. Coffman was also director of BristolMyers Squibb Company, a pharmaceutical company, and a member of its Audit and Governance Committees, from 1998 to 2007. Dr. Coffman was the Chairman of the Board and Chief Executive Officer of Lockheed Martin Corporationrationration, an aerospace and defense company, from 1998 to 2005, and was ex officio member of all board committees. From 1997 to 1998, he was Vice Chairman of the Board and Chief Executive Officer of Lockheed Martin. He is currently on the Board of Trustees of the Naval Postgraduate School Foundation, the Stanford Engineering Advisory Council of Stanford University and the Board of Governors of the Iowa State University Foundation. Dr. Coffman was a Member of the National Academy of Engineering since 1997 and a Fellow of the American Institute of Aeronautics and Astronautics and the American Astronautical Society since 1989 and 1997, respectively
Age: 71  Director Since 2013  Ph.D    
805 447-1010  www.amgen.com
Coffman received an undergraduate degree from Iowa State University and a doctorate from Stanford University.

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

W FarrellAbbott Laboratories
2006
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Douglas IngramEndo International plc
2016
Shane CookeEndo International plc
2014
James FarrellAbbott Laboratories
2006
Samuel ScottAbbott Laboratories
2007
Robert MalchioneBio Rad Laboratories Inc
2014
Sally BlountAbbott Laboratories
2011
Fred WeissAllergan plc
2013
Roxanne AustinAbbott Laboratories
2000
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
William SpenglerEndo International plc
2008
Nancy HutsonEndo International plc
2009
Ron TaylorAllergan plc
2013
Daniel StarksAbbott Laboratories
2017
Arthur HigginsEndo International plc
2013
Nesli BasgozAllergan plc
2014
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Joseph BoccuziAllergan plc
2017
Michael GallagherAllergan plc
2015
James BloemAllergan plc
2013

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio File Import Now
   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
Hide  View All  NextLaunch Portfolio File Import
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators